Last reviewed · How we verify
Diabetic gastroparesis
Approved treatments
- Metaclopramide · Institute of Liver and Biliary Sciences, India
- Reglan · Hikma
- Reglan · Hikma
Metoclopramide stimulates upper GI tract motility by sensitizing tissues to acetylcholine action.
Clinical guidelines
- FDA label — 1L
Relief of symptoms in adults with acute and recurrent diabetic gastroparesis.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Diabetic gastroparesis patent landscape — cliff calendar, originator estates, attackable patents
- Diabetic gastroparesis treatment landscape brief
- Diabetic gastroparesis treatment updates RSS
Frequently asked questions about Diabetic gastroparesis
What drugs treat Diabetic gastroparesis?
Tracked treatments include Metaclopramide, Reglan.
What is the treatment for Diabetic gastroparesis?
Standard treatment for Diabetic gastroparesis includes Metaclopramide, Reglan. See the treatment landscape page for first-line, second-line and salvage options.
What are the treatment guidelines for Diabetic gastroparesis?
FDA label publishes guidelines for Diabetic gastroparesis. 1 guideline references tracked.
Related
- Treatment landscape: Diabetic gastroparesis patent cliff · Diabetic gastroparesis CI report
- Treatment: Metaclopramide · Institute of Liver and Biliary Sciences, India
- Treatment: Reglan · Hikma
- Treatment: Reglan · Hikma
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing